Immunotherapy of AMLs: Development of vaccines and cell therapy approaches.

2003 DEC 18 - (NewsRx.com & NewsRx.net) -- Researchers review the development of vaccines and cell therapy approaches for the treatment of acute myeloid leukemias in a recent issue of the Bulletin du Cancer.

"Prognosis of acute myeloblastic leukemias (AML) remains with relapse, at a time when progress in chemotherapy regimens have increased the rate of complete remission, and improved biological tools have helped in defining diagnostic and prognostic criteria for this heterogeneous group of diseases. Allogeneic stem cell transplantation offers an example of a situation in which various immune effectors can contribute to the eradication of residual leukemic cells. …